HCW Biologics (HCWB) Asset Utilization Ratio (2022 - 2026)

HCW Biologics (HCWB) has reported Asset Utilization Ratio for 5 consecutive years, with 0.01 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Asset Utilization Ratio fell 76.13% year-over-year to 0.01; the trailing twelve-month figure through Jun 2026 stood at 0.01 (down 76.13% YoY), and the FY2025 full-year result was 0.0, down 97.73% from the prior year.
• Asset Utilization Ratio climbed to 0.01 in Q2 2026 per HCWB's latest filing, from 0.0 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.14 in Q2 2024 and bottomed at 0.0 in Q4 2025.
• Historically, Asset Utilization Ratio has averaged 0.08 across 5 years, with a median of 0.08 in 2023.
• The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio jumped 72.03% in 2024, then tumbled 97.6% in 2025.
• Over 5 years, Asset Utilization Ratio stood at 0.14 in 2022, then sank by 35.29% to 0.09 in 2023, then advanced by 1.99% to 0.09 in 2024, then sank by 97.6% to 0.0 in 2025, then jumped by 231.86% to 0.01 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.01, 0.0, and 0.02 for Q2 2026, Q4 2025, and Q3 2025 respectively.